Specialty Vaccine Company PaxVax Appoints Mark Meltz Executive Vice President and Chief Legal Officer

September 3, 2014 PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced the appointment of Mark Meltz as Executive Vice President and Chief Legal Officer. In this role, Mr. Meltz will oversee all legal, intellectual property, business development, government affairs, compliance and corporate governance matters for the company. Mr. Meltz joins PaxVax from Biogen Idec, where …